DOE accelerates evaluation of new medical radioisotopes

April 13, 2022, 12:00PMNuclear News

The Department of Energy announced on April 11 that it will distribute $1 million to three awardees to evaluate newly developed radioisotopes for potential therapeutic use in preclinical and clinical trials. The funding is provided by the DOE Isotope Program, which produces isotopes for use in science, medicine, and industry that would otherwise be unavailable or in short supply.

To continue reading, log in or create a free account!

Related Articles

Oklo secures DOE PDSA approval

June 12, 2026, 2:14PMNuclear News

On Thursday, Oklo announced that the Department of Energy’s Idaho Operations Office had approved the preliminary documented safety analysis (PDSA) for the company’s first deployment of its...

Nuclear EOs: One year later

May 22, 2026, 12:46PMNuclear News

This Saturday, May 23, will mark one year since President Trump issued four executive orders (EOs) that sought to implement sweeping changes across the U.S. nuclear industry. From regulatory...